Basic Information
Aldropika Therapeutics focuses on developing topical treatments for ophthalmic diseases. Its lead program is advancing small molecule therapies targeting a condition known as wet age-related macular degeneration (AMD).
Aldropika Therapeutics Pte. Ltd.
Singapore
unclear
January 13, 2021
--
--
Enterprise Profile
Industrial Sector
Concept
Application Scenarios